Although TIMP1 is a natural inhibitor of MMPs involved in the matrix remodeling during carcinogenesis, it converges toward cancer cell survival by binding MMP9/CD44 complex and mediating PI3K/AKT pathway activation27,28. Here, CD44 is linked to cancer.